Drug discovery

Vaccine
#Clinical trials #Drug discovery #Infectious diseases #Vaccines

Research programme represents a “new frontier in vaccine science” 

The UK’s University of Oxford, through its strategic partnership with the Ellison Institute of Technology (EIT), has received research funding of £118 ($159.7) million to launch an ambitious new programme of vaccine research.  Led by the Oxford Vaccine Group, the new initiative based in the University – CoI-AI (Correlates of… Read More

#Business & Investment #News

Eye health ophthalmology
#Clinical trials #Drug discovery #Gene therapy #Ophthalmology

Advancing gene-agnostic therapies for inherited retinal diseases 

DDW’s Megan Thomas speaks with Dr Arun Upadhyay, Chief Scientific Officer, Head of Research & Development at Ocugen, about the development of gene-agnostic modifier therapies for inherited retinal diseases, highlighting pathway discovery, preclinical models, dosing strategies, biomarker integration, and the potential expansion of this approach beyond ophthalmology.  MT: How does… Read More

#Exclusive Content #News

#Drug discovery #Flow Cytometry

Advance your flow cytometry research with spectral flow protocols

This handbook provides practical insights and application data to serve as a truly helpful guide for adapting to spectral flow cytometry—an advanced technology that elevates flow cytometry to the next level. In this handbook, you’ll find: Step-by-step protocols tailored for spectral flow cytometry Real-world application examples to guide your experiments… Read More

#Resources

#Drug discovery

App Notes – Get the scoop on Fluorescent Western Blotting

Looking to transition to fluorescent western blotting or wanting to maximise the output of your multiplex western blotting experiment? These two app notes cover all the essentials and more:  Best practices Troubleshooting tips  Easy to follow protocols Brought to you by    Copyright 2025 Drug Discovery World. Read More

#App Notes

Molecules
#AI #AI / data analytics / healthtech / informatics #Compounds #Drug discovery #Library screening

The evolution of chemical collections and drug-like diversity 

Andrea Altieri, Chief Scientific Officer, and Diana Zelencova-Gopejenko, Chief Executive Officer, Molport, explore how curated compound libraries—and the platforms that support them—are transforming the landscape of modern screening campaigns in drug discovery.  The development of screening libraries has closely followed advances in medicinal chemistry, computational methods, and molecular biology. In… Read More

#Exclusive Content

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Evaluate billions of compounds in record time

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Clinical trials #Drug discovery #National Institute for Health Research #UK

New network to boost industry clinical trials in the UK

The National Institute for Health and Care Research (NIHR) has awarded £6.5 (£8.7) million, funded jointly through a public-private partnership with the pharmaceutical industry, to establish a UK-wide Commercial Research Delivery Centre (CRDC) Network.   The new Network will provide strategic coordination of all 21 CRDCs across the… Read More

#News

#Drug discovery #European Medicines Agency #FDA #Health Canada #Regulatory

This week in drug discovery (25-29 August) 

News round-up for 25-29 August by DDW Senior Digital Content Editor Diana Turner. There have been some significant regulatory decisions this week, including a new orphan designation from the EMA and the FDA go-ahead for Rocket Pharma’s paused gene therapy trial. The top stories:… Read More

#News

#Drug discovery

Handbook – Advance your flow cytometry research with spectral flow protocols

This handbook provides practical insights and application data to serve as a truly helpful guide for adapting to spectral flow cytometry—an advanced technology that elevates flow cytometry to the next level.  In this handbook, you’ll find: Step-by-step protocols tailored for spectral flow cytometry Real-world application examples to guide your experiments… Read More

#Guides

#Aptamer Group #Aptamers #Biomarkers #Drug discovery

Aptamer launches biomarker discovery service

Aptamer Group has launched its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development a new approach to identify and validate new disease markers.  The service integrates Aptamer’s Optimer technology with proteomic analysis to provide an unbiased, high-throughput approach to biomarker identification.   This… Read More

#News

#Drug discovery #Foundational model #Genomics #Large language model (LLM) #Machine learning #Merck #Open source

Merck shares foundation model with the research community

Merck is expanding access to TEDDY (Transformers for Enabling Drug DiscoverY), its foundation model for drug discovery, by adding it to HuggingFace, the premier platform for open-source machine learning and LLMs.  TEDDY was created in partnership with the Boston Consulting Group (BCG) AI Science Institute and is… Read More

#News

RNA
#Academic #Drug discovery #Single-cell analysis #Single-cell RNA sequencing

AI biotech company gives free access to single-cell sequencing

A new programme is offering academic researchers free access to advanced single-cell RNA sequencing to accelerate discovery across cancer and autoimmunity.  Immunai’s new academic initiative to support human immunology research is called the Immunai Grand Collaboration Initiative for Single-Cell Immune Profiling.  Through the programme, academic… Read More

#News

Cancer research
#Cancer research #Drug development #Drug discovery #Interview #START Center for Cancer Research (START) #Vodcast

New vodcast: In Conversation With Nick Slack, START Center for Cancer Research

In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More

#News

Cancer research
#Cancer research #Drug development #Drug discovery #Interview #START Center for Cancer Research (START) #Vodcast

Vodcast: In Conversation With Nick Slack, START Centre for Cancer Research

In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More

#Videos

#Business #Drug discovery

Turning Science into Business Symposium (DDW)

  The DDW Turning Science into Business Symposium will take place in the afternoon on Tuesday 4 November 2025 at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK. This is a half day conference. Programme 12.30-1.15PM… Read More

#Webinars

Genomics concept
#AI / data analytics / healthtech / informatics #Drug discovery #eBook #Multi-omics

eBook: Omics-driven drug discovery

A new eBook is now available for download for free from DDW and Evotec. One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from… Read More

#News